Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety Evaluation of Pterygopalatine Ganglion Stimulation in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Controlled Pilot Study

NCT07570355 is registered in ClinicalTrials.gov with Shanghai Institute of Acupuncture, Moxibustion and Meridian as lead sponsor.

NCT NCT07570355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07570355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety Evaluation of Pterygopalatine Ganglion Stimulation in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Controlled Pilot Study
Lead sponsor
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
July 31, 2028
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

geographic atrophy